Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women

Human Reproduction

Volumn 29, Issue 9, 2014, Pages 1987-1994

  Bertone Johnson, E R ^a   Ronnenberg, A G ^a   Houghton, S C ^a   Nobles, C ^a   Zagarins, S E ^a,b   Takashima Uebelhoer, B B ^a   Faraj, J L ^a   Whitcomb, B W ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b BAYSTATE MEDICAL CENTER   (United States)

Author keywords

cytokines; inflammation; menstrual cycle; premenstrual syndrome

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; IL10 PROTEIN, HUMAN; IL2 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; LIFESTYLE; LUTEAL PHASE; MAJOR CLINICAL STUDY; PREMENSTRUAL SYNDROME; SMOKING; BLOOD; METABOLISM; PATHOLOGY; STATISTICAL MODEL; YOUNG ADULT;

BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-4; LINEAR MODELS; PREMENSTRUAL SYNDROME; YOUNG ADULT;

EID: 84906091308     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu170     Document Type: Article

References (54)

1. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR Jr, Montoye HJ, Sallis JF, Paffenbarger RS Jr. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993; 25:71-80. (Pubitemid 23027685)
2. Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, Salehi B, Mohebbi- Rasa S, Raznahan M, Kamalipour A. Clinical trial of adjunctive celecoxib treatment in patients with major depression: A double blind and placebo controlled trial. Depress Anxiety 2009;26:607-611.
3. Asnis GM, De la Garza R 2nd, Kohn SR, Reinus JF, Henderson M, Shah J. IFN-induced depression: a role for NSAIDs. Psychopharmacol Bull 2003; 37:29-50.
4. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-920.
5. Belmaker RH, Agam G. Major depressive disorder. N Engl J Med 2008; 358:55-68.
6. Bertone-Johnson ER, Hankinson SE, Bendich A, Johnson SR, Willett WC, Manson JE. Calcium and vitamin D intake and risk of incident premenstrual syndrome. Arch Intern Med 2005;165:1246-1252. (Pubitemid 40989588)
7. Bertone-Johnson ER, Hankinson SE, Johnson SR, Manson JE. A simple method of assessing premenstrual syndrome in large prospective studies. J Reprod Med 2007;52:779-786.
8. Bertone-Johnson ER, Hankinson SE, Johnson SR, Manson JE. Timing of alcohol use and the incidence of premenstrual syndrome and probable premenstrual dysphoric disorder. J Women's Health 2009; 18:1945-1953.
9. Bertone-Johnson ER, Chocano-Bedoya PO, Zagarins SE, Micka AE, Ronnenberg AG. Dietary vitamin D intake, 25-hydroxyvitamin D(3) levels and premenstrual syndrome in a college-aged population. J Steroid Biochem Mol Biol 2010;121:434-437.
10. Bertone-Johnson E, Mumford S, Pollack A, Luisi N, Wactawski-Wende J, Schisterman E, Whitcomb B. Premenstrual syndrome and cytokine levels across the menstrual cycle [abstract]. Am J Epidemiol 2011; 173(Suppl 11):S603.
11. Blum CA, Muller B, Huber P, Kraenzlin M, Schindler C, DeGeyter C, Keller U, Puder JJ. Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women. J Clin Endocrinol Metab 2005;90:3230-3235. (Pubitemid 41014280)
12. Brannstrom M, Normal RJ, Seamark RF, Robertson SA. Rat ovary produces cytokines during ovulation. Biol Reprod 1994;50:88-94. (Pubitemid 24006012)
13. Brennan AM, Fargnoli JL, Williams CJ, Li T, WillettW, Kawachi I, Qi L, Hu FB, Mantzoros CS. Phobic anxiety is associated with higher serum concentrations of adipokines and cytokines in women with diabetes. Diabetes Care 2009;32:926-931.
14. Carson RT, Vignali DAA. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Meth 1999;227: 41-52. (Pubitemid 29408703)
15. Conti P, Kempuraj D, Kandere K, Di Gioacchino M, Barbacane RC, Castellani ML, Felaco M, Boucher W, Letourneau R, Theoharides TC. IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett 2003;86:123-129. (Pubitemid 36324272)
16. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-56. (Pubitemid 350295688)
17. Dinarello CA. Historical review of cytokines. Eur J Immunol 2007;37(Suppl 1):S34-S45.
18. Evans J, Salamonsen LA. Inflammation, leukocytes and menstruation. Rev Endocr Metab Disord 2012;13:277-288.
19. Facchinetti F, Fioroni L, Sances G, Romano G, Nappi G, Genazzani AR. Naproxen sodium in the treatment of premenstrual symptoms. A placebo-controlled study. Gynecol Obstet Invest 1989;28:205-208. (Pubitemid 20009993)
20. Gorai I, Taguchi Y, Chaki O, Kikuchi R, Nakayama M, Yang BC, Yokota S, Minaguchi H. Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle. J Clin Endocrinol Metab 1998;83:326-332. (Pubitemid 28496500)
21. Gaskins AJ, Wilchesky M, Mumford SL, Whitcomb BW, Browne RW, Wactawski-Wende J, Perkins NJ, Schisterman EF. Endogenous reproductive hormones and C-reactive protein across the menstrual cycle: the BioCycle Study. Am J Epidemiol 2012;175:423-431.
22. Halbreich U. The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology 2003;28(Suppl 3):55-99. (Pubitemid 39658678)
23. Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003;28(Suppl 3):1-23. (Pubitemid 39658675)
24. HornungRW, Reed LD. Estimation of average concentration in the presence of non-detectable values. Appl Occup Environ Hyg 1990;5:46-51. (Pubitemid 20094575)
25. Johnson SR. The epidemiology and social impact of premenstrual symptoms. Clin Obstet Gynecol 1987;30:367-376. (Pubitemid 17090229)
26. King AE, Critchley HO. Oestrogen and progesterone regulation of inflammatory processes in the human endometrium. J Steroid Biochem Mol Biol 2010;120:116-126.
27. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65:732-741.
28. Mortola JF, Girton L, Beck L, Yen SS. Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol 1990;76:302-307. (Pubitemid 20227477)
29. Muller N. COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence. Curr Opin Investig Drugs 2010;11:31-42.
30. Myers JS. Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms. Oncol Nurs Forum 2008; 35:802-807.
31. Nie L, Chu H, Liu C, Cole SR, Vexler A, Schisterman EF. Linear regression with an independent variable subject to a detection limit. Epidemiol 2010;21(suppl 4):S17-S24.
32. Paolo JA, Lee LK, Wu B, Banks PA, Steen H, Conwell DL. Cytokine profiling of pancreatic fluid using the ePFT collection method in tandem with a multiplexed microarray assay. J Immunol Methods 2011; 369:98-107.
33. Peterlin BL, Bigal ME, Tepper SJ, Urakaze M, Sheftell FD, Rapoport AM. Migraine and adiponectin: is there a connection? Cephalalgia 2007; 27:435-446. (Pubitemid 46646541)
34. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003; 108:155-160. (Pubitemid 36871296)
35. Puder JJ, Blum CA, Mueller B, De Geyter C, Dye L, Keller U. Menstrual cycle symptoms are associated with changes in low-grade inflammation. Eur J Clin Invest 2006;36:58-64.
36. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31. (Pubitemid 43083561)
37. Schisterman EF, Vexler A, Whitcomb BW, Liu A. The limitations due to exposure detection limits for regression models. Am J Epidemiol 2006; 163:374-383. (Pubitemid 43238432)
38. Schisterman EF, Mumford SL, Sjaarda LA. Failure to consider the menstrual cycle phase may cause misinterpretation of clinical and research findings of cardiometabolic biomarkers in premenopausal women. Epidemiol Rev 2014;36:71-82.
39. Simon C, Polan ML. Cytokines and reproduction. West J Med 1994; 160:425-429. (Pubitemid 24155879)
40. Smith RS. The macrophage theory of depression. Med Hypotheses 1991; 35:298-306.
41. Steinman L.Abrief historyofTH17, the firstmajor revision in theTH1/TH2 hypothesis of T cell-mediated tissue damage. Nat Med 2007;13: 139-145.
42. Suarez EC. C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. Psychosom Med 2004; 66:684-691. (Pubitemid 39332354)
43. Tan KS. Premenstrual asthma: Epidemiology, pathogenesis and treatment. Drugs 2001;61:2079-2086. (Pubitemid 33135184)
44. Tehrani R, Dharmalingam M. Management of premenstrual acne with cox-2 inhibitors: a placebo controlled study. Indian J Dermatol Venereol Leprol 2004;70:345-348.
45. von Wolff M, Thaler CJ, Strowitzki T, Broome J, Stolz W, Tabibzadeh S. Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion. Mol Hum Reprod 2000;6:627-634. (Pubitemid 30470094)
46. Wander K, Brindle E, O'Connor KA. C-reactive protein across the menstrual cycle. Am J Phys Anthropol 2008;136:138-146. (Pubitemid 351742812)
47. Watson D, O'Hara MW, Simms LJ, Kotov R, Chmielewski M, McDade- Montez EA, Gamez W, Stuart S. Development and validation of the Inventory of Depression and Anxiety Symptoms (IDAS). Psychol Assess 2007;19:253-268. (Pubitemid 47488883)
48. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122:51-65. (Pubitemid 15010435)
49. Whitcomb BW, Lynch KE, Mumford SL, Bertone-Johnson ER, Wactawski- Wende J, Schisterman EF. Temporal variability of cytokines across the menstrual cycle in healthy, reproductive age women. Fertil Steril 2014; 101:1383-1391.
50. Wolf AM, Hunter DJ, Colditz GA, Manson JE, Stampfer MJ, Corsano KA, Rosner B, Kriska A, Willett WC. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol 1994; 23:991-999. (Pubitemid 24331214)
51. Yanagi K, Makinoda S, Fujii R, Miyazaki S, Fujita S, Tomizawa H, Yoshida K, Iura T, Takegami T, Nojima T. Cyclic changes of granulocyte colony-stimulating factor (G-CSF) mRNA in the human follicle during the normal menstrual cycle and immunolocalization of G-CSF protein. Hum Reprod 2002;17:3046-3052. (Pubitemid 35469251)
52. Yonkers KA, O'Brien PM, Eriksson E. Premenstrual syndrome. Lancet 2008; 371:1200-1210. (Pubitemid 351458526)
53. Yoshimura R, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Ueda N, Nakamura J. Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:722-726.
54. Zagarins SE, Ronnenberg AG, Gehlbach SH, Lin R, Bertone-Johnson ER. Fat mass is detrimental to bone mass in young premenopausal women. J Clin Densitom 2010;13:392-398.